New biomarkers in the risk stratification of patients with suspected acute myocardial infarction.

Journal Article (Journal Article;Review)

The acute coronary syndromes (ACS) remain a diagnostic and prognostic challenge for today's physician. Over the past decade, studies have identified several serologic biomarkers to aid the clinician in assessing risk and predicting outcomes in ACS. Still others are being identified that show promise for increasing the accuracy with which this risk is assessed. However, further research remains necessary to identify the perfect cardiac biomarker or combination of markers and to define their roles in clinical management of ACS patients.

Full Text

Duke Authors

Cited Authors

  • Rogers, BA; Newby, LK

Published Date

  • July 2002

Published In

Volume / Issue

  • 4 / 4

Start / End Page

  • 341 - 347

PubMed ID

  • 12052274

International Standard Serial Number (ISSN)

  • 1523-3782

Digital Object Identifier (DOI)

  • 10.1007/s11886-002-0071-z


  • eng

Conference Location

  • United States